Google
SOPH 株価分析 — SOPHIA GENETICS SA (Healthcare >> Health Information Services)
SOPH に関するよくある質問
SOPHのROE（自己資本利益率）は？
SOPHIA GENETICS SAのROEは-177.15%です。
SOPHの配当利回りは？
SOPHIA GENETICS SAの配当利回りは0.00%です。
SOPHの品質スコア（Quality Score）は？
当社のAIはSOPHの総合財務品質を100点中15点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。
SOPHは今が買い時ですか？
当社AIのタイミングスコアは100点中70点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。
SOPHはどのセクターに属しますか？
SOPHIA GENETICS SAはHealthcare >> Health Information Servicesセクターに分類されます（NASDAQ市場）
SOPH AI Analysis Summary
Our AI summary for SOPH: SOPHIA GENETICS SA (NASDAQ), Healthcare >> Health Information Services sector. The stock currently trades at a P/E of 0.00, ROE of -177.15%, a dividend yield of 0.00%. Its financial Quality Score stands at 15/100 — fundamentals below the market average. The AI Timing Score is 70/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 5.67
Price
-0.09
(-1.56%)
Day Change
|
|
|---|
SOPH, ファンダメンタルスコアはnot good ( ファンダメンタル = 15) but テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROEが低い
ROAが低い
平均ROEが低い
昨年度のROEが一昨年比で低い
ROEが昨年度比で低い
ROAの伸びが低い
Last-year ROA is lower than last-2-years ROA.
昨年度のROAが一昨年比で低い
NPMが低い
NPMの伸びが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...
| Deepscope 分析 |
|
45% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 91 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 5.67 |
| PBV / Sector |
10.58 / 6.33
|
| Earning Per Share | -0.95 |
| PE / Sector |
N/A / 46.50
|
| PEG or PE/Growth / Sector |
N/A / -0.41
|
| Average 1M Daily Value |
1.75 M
GREAT
|
| Average 1W Daily Value |
0.93 M
GREAT
|
| Timing Factors |
|
28% |
| Financial Health |
|
43% |
| ポイントになる統計 |
|
54% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-08-01 08:00:30 |
| Symbol | SOPH |
| Name | SOPHIA GENETICS SA |
| Sector | Healthcare >> Health Information Services |
| Market | NASDAQ |
| Listed Shares | 83.90 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 483.24 / 4,079.00 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: La PiEce 12, Rolle, Switzerland, 1180
Phone: 41 21 694 10 60
Website: https://www.sophiagenetics.com
Employees: 415
Description: SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. It offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. The company has a partnership with Synnovis to bring blood-based cancer testing to patients in the United Kingdom. The company was incorporated in 2011 and is based in Rolle, Switzerland.
Analyst Ratings & Target Price
ME vs SECTOR Healthcare >> Health Information Services
Click a bubble to view stock details · Bubble size represents market capitalization share
